Evaluation of a Cerebral-Blood-Volume (CBV) pharmaco-MRI (phMRI) assay utilizing low (0.1mg/70kg) and high (0.2mg/70kg) dose buprenorphine infusion and a novel USPIO contrast agent (Ferumoxytol) in healthy human subjects
- Publication date
- 1 January 2015
- Publisher
- International Society of Magnetic Resonance in Medicine (ISMRM)